$BLGO
BIOLARGO, INC.

2021 Q4 Form 10-Q Financial Statement

#000143774921026755 Filed on November 15, 2021

View on sec.gov

Income Statement

Concept 2021 Q4 2021 Q3 2020 Q4
Revenue $788.0K $712.0K $910.0K
YoY Change -13.41% 6.91% 69.46%
Cost Of Revenue $465.0K $362.0K $443.0K
YoY Change 4.97% 20.27% 71.04%
Gross Profit $323.0K $350.0K $467.0K
YoY Change -30.84% -4.11% 67.99%
Gross Profit Margin 40.99% 49.16% 51.32%
Selling, General & Admin $1.406M $1.461M $2.128M
YoY Change -33.93% -24.18% 29.6%
% of Gross Profit 435.29% 417.43% 455.67%
Research & Development $340.0K $344.0K $310.0K
YoY Change 9.68% -0.86% -10.4%
% of Gross Profit 105.26% 98.29% 66.38%
Depreciation & Amortization $3.000K $5.000K $8.000K
YoY Change -62.5% -70.59% -52.94%
% of Gross Profit 0.93% 1.43% 1.71%
Operating Expenses $1.746M $1.805M $2.435M
YoY Change -28.3% -20.62% 25.52%
Operating Profit -$1.423M -$1.455M -$1.968M
YoY Change -27.69% -23.78% 18.41%
Interest Expense -$26.00K $26.00K -$100.0K
YoY Change -74.0% -91.82% -91.82%
% of Operating Profit
Other Income/Expense, Net $43.00K $18.00K $75.00K
YoY Change -42.67% -103.74% 7.14%
Pretax Income -$1.791M -$1.435M -$1.993M
YoY Change -10.14% -39.96% -29.2%
Income Tax
% Of Pretax Income
Net Earnings -$2.526M -$1.435M -$1.626M
YoY Change 55.35% -39.96% -38.34%
Net Earnings / Revenue -320.56% -201.54% -178.68%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$9.782K -$5.144K -$10.00K
COMMON SHARES
Basic Shares Outstanding 257.7M 252.9M 222.4M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q4 2021 Q3 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $962.0K $1.098M $716.0K
YoY Change 34.36% -1.7% 9.31%
Cash & Equivalents $962.0K $1.098M $716.0K
Short-Term Investments
Other Short-Term Assets $85.00K $99.00K $28.00K
YoY Change 203.57% 94.12% -28.21%
Inventory $241.0K $250.0K $277.0K
Prepaid Expenses
Receivables $513.0K $464.0K $484.0K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.801M $1.911M $1.505M
YoY Change 19.67% 2.03% 41.31%
LONG-TERM ASSETS
Property, Plant & Equipment $61.00K $64.00K $60.00K
YoY Change 1.67% 52.38% -36.84%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $48.00K $40.00K $63.00K
YoY Change -23.81% -45.21%
Other Assets $69.00K $35.00K $35.00K
YoY Change 97.14% -95.75% 0.0%
Total Long-Term Assets $1.222M $3.373M $3.437M
YoY Change -64.45% 1.75% 34.47%
TOTAL ASSETS
Total Short-Term Assets $1.801M $1.911M $1.505M
Total Long-Term Assets $1.222M $3.373M $3.437M
Total Assets $3.023M $5.284M $4.942M
YoY Change -38.83% 1.85% 36.48%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $350.0K $771.0K $315.0K
YoY Change 11.11% 62.32% 61.54%
Accrued Expenses $393.0K $496.0K $312.0K
YoY Change 25.96% 22.47% 19.08%
Deferred Revenue $89.00K $162.0K $48.00K
YoY Change 85.42% 125.0% 37.14%
Short-Term Debt $0.00 $1.007M $1.231M
YoY Change -100.0% -21.33% 11.2%
Long-Term Debt Due $314.0K $0.00 $1.102M
YoY Change -71.51% -100.0% -55.65%
Total Short-Term Liabilities $1.374M $2.515M $3.544M
YoY Change -61.23% -21.14% -18.6%
LONG-TERM LIABILITIES
Long-Term Debt $180.0K $489.0K $507.0K
YoY Change -64.5% -3.55% -27.57%
Other Long-Term Liabilities $349.0K $1.081M $1.126M
YoY Change -69.01% 6.82% 21.21%
Total Long-Term Liabilities $716.0K $1.766M $1.633M
YoY Change -56.15% 248.32% 133.29%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.374M $2.515M $3.544M
Total Long-Term Liabilities $716.0K $1.766M $1.633M
Total Liabilities $2.090M $4.281M $5.177M
YoY Change -59.63% -9.07% -10.76%
SHAREHOLDERS EQUITY
Retained Earnings -$139.1M -$136.6M -$132.0M
YoY Change 5.36% 4.75% 6.92%
Common Stock $171.0K $171.0K $151.0K
YoY Change 13.25% 15.54% 36.04%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $4.653M $4.809M $3.858M
YoY Change
Total Liabilities & Shareholders Equity $3.023M $5.284M $4.942M
YoY Change -38.83% 1.85% 36.48%

Cashflow Statement

Concept 2021 Q4 2021 Q3 2020 Q4
OPERATING ACTIVITIES
Net Income -$2.526M -$1.435M -$1.626M
YoY Change 55.35% -39.96% -38.34%
Depreciation, Depletion And Amortization $3.000K $5.000K $8.000K
YoY Change -62.5% -70.59% -52.94%
Cash From Operating Activities -$975.0K -$908.0K -$836.0K
YoY Change 16.63% -28.56% -32.63%
INVESTING ACTIVITIES
Capital Expenditures -$13.00K $0.00 -$23.00K
YoY Change -43.48% 187.5%
Acquisitions
YoY Change
Other Investing Activities $0.00 $0.00 -$4.000K
YoY Change -100.0% -100.0%
Cash From Investing Activities -$13.00K $0.00 -$27.00K
YoY Change -51.85% -100.0% 237.5%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 857.0K 656.0K 456.0K
YoY Change 87.94% -46.36% -303.57%
NET CHANGE
Cash From Operating Activities -975.0K -908.0K -836.0K
Cash From Investing Activities -13.00K 0.000 -27.00K
Cash From Financing Activities 857.0K 656.0K 456.0K
Net Change In Cash -131.0K -252.0K -407.0K
YoY Change -67.81% 320.0% -72.37%
FREE CASH FLOW
Cash From Operating Activities -$975.0K -$908.0K -$836.0K
Capital Expenditures -$13.00K $0.00 -$23.00K
Free Cash Flow -$962.0K -$908.0K -$813.0K
YoY Change 18.33% -34.06%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
257726382
CY2021Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
USD
CY2021Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00067
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.00067
CY2021Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
50000000
CY2021Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q3 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00067
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.00067
CY2021Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
255885682
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2021Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
255368553
CY2021Q3 blgo Number Of Wholly Owned Subsidiaries
NumberOfWhollyOwnedSubsidiaries
4 pure
CY2020Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
13000 USD
CY2020Q4 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3000 USD
CY2021Q3 us-gaap Inventory Valuation Reserves
InventoryValuationReserves
3000 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2020Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
296000 USD
us-gaap Number Of Operating Segments
NumberOfOperatingSegments
4 pure
CY2021Q3 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P2Y
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1098000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
716000 USD
CY2021Q3 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
464000 USD
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
484000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
250000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
277000 USD
CY2021Q3 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
99000 USD
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
28000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
1911000 USD
CY2020Q4 us-gaap Assets Current
AssetsCurrent
1505000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2150000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2150000 USD
CY2021Q3 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
64000 USD
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
60000 USD
CY2021Q3 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35000 USD
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
35000 USD
CY2021Q3 us-gaap Equity Method Investments
EquityMethodInvestments
40000 USD
CY2020Q4 us-gaap Equity Method Investments
EquityMethodInvestments
63000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
296000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
341000 USD
CY2021Q3 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
788000 USD
CY2020Q4 us-gaap Prepaid Expense Noncurrent
PrepaidExpenseNoncurrent
788000 USD
CY2021Q3 us-gaap Assets Noncurrent
AssetsNoncurrent
3373000 USD
CY2020Q4 us-gaap Assets Noncurrent
AssetsNoncurrent
3437000 USD
CY2021Q3 us-gaap Assets
Assets
5284000 USD
CY2020Q4 us-gaap Assets
Assets
4942000 USD
CY2021Q3 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
162000 USD
CY2020Q4 us-gaap Contract With Customer Liability Current
ContractWithCustomerLiabilityCurrent
48000 USD
CY2021Q3 blgo Liability For Customer Deposits Current
LiabilityForCustomerDepositsCurrent
79000 USD
CY2020Q4 blgo Liability For Customer Deposits Current
LiabilityForCustomerDepositsCurrent
0 USD
CY2021Q3 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
114000 USD
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
114000 USD
CY2021Q3 us-gaap Liabilities Current
LiabilitiesCurrent
2515000 USD
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
3544000 USD
CY2021Q3 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
181000 USD
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
226000 USD
CY2021Q3 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent
SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
900000 USD
CY2020Q4 us-gaap Shares Subject To Mandatory Redemption Settlement Terms Amount Noncurrent
SharesSubjectToMandatoryRedemptionSettlementTermsAmountNoncurrent
900000 USD
CY2021Q3 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1766000 USD
CY2020Q4 us-gaap Liabilities Noncurrent
LiabilitiesNoncurrent
1633000 USD
CY2021Q3 us-gaap Liabilities
Liabilities
4281000 USD
CY2020Q4 us-gaap Liabilities
Liabilities
5177000 USD
CY2021Q3 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0 USD
CY2021Q3 us-gaap Common Stock Value
CommonStockValue
171000 USD
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
151000 USD
CY2021Q3 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
141343000 USD
CY2020Q3 us-gaap Gross Profit
GrossProfit
365000 USD
us-gaap Gross Profit
GrossProfit
780000 USD
us-gaap Gross Profit
GrossProfit
761000 USD
CY2021Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1461000 USD
CY2020Q3 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
1927000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
4766000 USD
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
5345000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
344000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
347000 USD
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
135849000 USD
CY2021Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-110000 USD
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-101000 USD
CY2021Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-136595000 USD
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-132041000 USD
CY2021Q3 us-gaap Stockholders Equity
StockholdersEquity
4809000 USD
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
3858000 USD
CY2021Q3 us-gaap Minority Interest
MinorityInterest
-3806000 USD
CY2020Q4 us-gaap Minority Interest
MinorityInterest
-4093000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1003000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-235000 USD
CY2021Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
5284000 USD
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4942000 USD
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
712000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
666000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1743000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1522000 USD
CY2021Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
362000 USD
CY2020Q3 us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
301000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
963000 USD
us-gaap Cost Of Goods And Services Sold
CostOfGoodsAndServicesSold
761000 USD
CY2021Q3 us-gaap Gross Profit
GrossProfit
350000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1027000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1031000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1455000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1909000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5013000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5615000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
26000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
318000 USD
us-gaap Interest Expense
InterestExpense
208000 USD
us-gaap Interest Expense
InterestExpense
1823000 USD
CY2021Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
CY2020Q3 us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-228000 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-442000 USD
CY2021Q3 blgo Gain From Ppp Loan Forgiveness
GainFromPPPLoanForgiveness
0 USD
CY2020Q3 blgo Gain From Ppp Loan Forgiveness
GainFromPPPLoanForgiveness
0 USD
blgo Gain From Ppp Loan Forgiveness
GainFromPPPLoanForgiveness
43000 USD
blgo Gain From Ppp Loan Forgiveness
GainFromPPPLoanForgiveness
0 USD
CY2021Q3 blgo Tax Credit Income
TaxCreditIncome
21000 USD
CY2020Q3 blgo Tax Credit Income
TaxCreditIncome
65000 USD
blgo Tax Credit Income
TaxCreditIncome
50000 USD
blgo Tax Credit Income
TaxCreditIncome
109000 USD
CY2021Q3 blgo Nonoperating Income Grant Income
NonoperatingIncomeGrantIncome
25000 USD
CY2020Q3 blgo Nonoperating Income Grant Income
NonoperatingIncomeGrantIncome
0 USD
blgo Nonoperating Income Grant Income
NonoperatingIncomeGrantIncome
25000 USD
blgo Nonoperating Income Grant Income
NonoperatingIncomeGrantIncome
64000 USD
CY2021Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
18000 USD
CY2020Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-2106000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-4554000 USD
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-6806000 USD
CY2021Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
CY2020Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.01
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.02
CY2020Q3 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-481000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-90000 USD
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2092000 USD
blgo Deemed Dividend For The Change In Accounting For Derivative Liability
DeemedDividendForTheChangeInAccountingForDerivativeLiability
-901000 USD
CY2021Q3 us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
-1301000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-9000 USD
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-8000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-1442000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-2420000 USD
CY2021Q3 blgo Profit Loss Including Deemed Dividends For The Change Accounting For Derivative Liability
ProfitLossIncludingDeemedDividendsForTheChangeAccountingForDerivativeLiability
-1435000 USD
CY2020Q3 blgo Profit Loss Including Deemed Dividends For The Change Accounting For Derivative Liability
ProfitLossIncludingDeemedDividendsForTheChangeAccountingForDerivativeLiability
-2390000 USD
blgo Profit Loss Including Deemed Dividends For The Change Accounting For Derivative Liability
ProfitLossIncludingDeemedDividendsForTheChangeAccountingForDerivativeLiability
-5103000 USD
blgo Profit Loss Including Deemed Dividends For The Change Accounting For Derivative Liability
ProfitLossIncludingDeemedDividendsForTheChangeAccountingForDerivativeLiability
-7707000 USD
CY2021Q3 blgo Deemed Dividend For The Change In Accounting For Derivative Liability
DeemedDividendForTheChangeInAccountingForDerivativeLiability
-134000 USD
CY2020Q3 blgo Deemed Dividend For The Change In Accounting For Derivative Liability
DeemedDividendForTheChangeInAccountingForDerivativeLiability
-284000 USD
blgo Deemed Dividend For The Change In Accounting For Derivative Liability
DeemedDividendForTheChangeInAccountingForDerivativeLiability
-549000 USD
us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.04
CY2021Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
252912561
CY2020Q3 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
210212946
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
243529117
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
182959765
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-1435000 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-2390000 USD
us-gaap Profit Loss
ProfitLoss
-5103000 USD
us-gaap Profit Loss
ProfitLoss
-7707000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-30000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-5112000 USD
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-7715000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-134000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-284000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-549000 USD
us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
-901000 USD
CY2021Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-1308000 USD
CY2020Q3 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-2136000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4563000 USD
us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-6814000 USD
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-235000 USD
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
2106000 USD
CY2021Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
111000 USD
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
424000 USD
CY2021Q1 blgo Adjustments To Additional Paid In Capital Warrants And Conversion Feature Issued
AdjustmentsToAdditionalPaidInCapitalWarrantsAndConversionFeatureIssued
35000 USD
CY2021Q1 blgo Stockholders Equity Allocation Of Noncontrolling Interest From Subsidiarys Equity Issuance
StockholdersEquityAllocationOfNoncontrollingInterestFromSubsidiarysEquityIssuance
0 USD
CY2021Q1 us-gaap Profit Loss
ProfitLoss
-1878000 USD
CY2021Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2000 USD
CY2021Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
772000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
328000 USD
CY2021Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
1414000 USD
CY2021Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
60000 USD
CY2021Q2 blgo Stock Issued During Period Value Paid For Interest
StockIssuedDuringPeriodValuePaidForInterest
16000 USD
CY2021Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
330000 USD
CY2021Q2 blgo Stockholders Equity Allocation Of Noncontrolling Interest From Subsidiarys Equity Issuance
StockholdersEquityAllocationOfNoncontrollingInterestFromSubsidiarysEquityIssuance
0 USD
CY2021Q2 us-gaap Profit Loss
ProfitLoss
-1790000 USD
CY2021Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
0 USD
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1232000 USD
CY2021Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
600000 USD
CY2021Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
123000 USD
CY2021Q3 blgo Stock Issued During Period Value Exercise Of Warrants
StockIssuedDuringPeriodValueExerciseOfWarrants
60000 USD
CY2021Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
251000 USD
CY2021Q3 blgo Stockholders Equity Allocation Of Noncontrolling Interest From Subsidiarys Equity Issuance
StockholdersEquityAllocationOfNoncontrollingInterestFromSubsidiarysEquityIssuance
0 USD
CY2021Q3 us-gaap Profit Loss
ProfitLoss
-1435000 USD
CY2021Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000 USD
CY2021Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1003000 USD
CY2019Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2180000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
434000 USD
CY2020Q1 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
178000 USD
CY2020Q1 blgo Stock Issued During Period Value Paid For Interest
StockIssuedDuringPeriodValuePaidForInterest
4000 USD
CY2020Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
901000 USD
CY2020Q1 blgo Stock Issued During Period Value Financing Fees
StockIssuedDuringPeriodValueFinancingFees
-122000 USD
CY2020Q1 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
320000 USD
CY2020Q1 blgo Equity Increase Decrease Dividends Deemed Due To A New Accounting Principle Adoption
EquityIncreaseDecreaseDividendsDeemedDueToANewAccountingPrincipleAdoption
0 USD
CY2020Q1 blgo Stockholders Equity Allocation Of Noncontrolling Interest From Subsidiarys Equity Issuance
StockholdersEquityAllocationOfNoncontrollingInterestFromSubsidiarysEquityIssuance
0 USD
CY2020Q1 us-gaap Profit Loss
ProfitLoss
-2616000 USD
CY2020Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-2636000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
688000 USD
CY2020Q2 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
272000 USD
CY2020Q2 blgo Stock Issued During Period Value Paid For Interest
StockIssuedDuringPeriodValuePaidForInterest
30000 USD
CY2020Q2 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
560000 USD
CY2020Q2 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
528000 USD
CY2020Q2 blgo Stockholders Equity Allocation Of Noncontrolling Interest From Subsidiarys Equity Issuance
StockholdersEquityAllocationOfNoncontrollingInterestFromSubsidiarysEquityIssuance
0 USD
CY2020Q2 us-gaap Profit Loss
ProfitLoss
-2700000 USD
CY2020Q2 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
22000 USD
CY2020Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
-1604000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
2405000 USD
CY2020Q3 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
93000 USD
CY2020Q3 blgo Stock Issued During Period Value Paid For Interest
StockIssuedDuringPeriodValuePaidForInterest
150000 USD
CY2020Q3 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
919000 USD
CY2020Q3 us-gaap Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition
AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition
499000 USD
CY2020Q3 blgo Adjustments To Additional Paid In Capital Loss On Extinguishment Of Debt
AdjustmentsToAdditionalPaidInCapitalLossOnExtinguishmentOfDebt
228000 USD
CY2020Q3 blgo Adjustments To Additional Paid In Capital Shares Issued As Commitment Fee
AdjustmentsToAdditionalPaidInCapitalSharesIssuedAsCommitmentFee
70000 USD
CY2020Q3 blgo Stockholders Equity Allocation Of Noncontrolling Interest From Subsidiarys Equity Issuance
StockholdersEquityAllocationOfNoncontrollingInterestFromSubsidiarysEquityIssuance
0 USD
CY2020Q3 us-gaap Profit Loss
ProfitLoss
-2390000 USD
CY2020Q3 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-30000 USD
CY2020Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
480000 USD
us-gaap Profit Loss
ProfitLoss
-5103000 USD
us-gaap Profit Loss
ProfitLoss
-7707000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1447000 USD
us-gaap Share Based Compensation
ShareBasedCompensation
1712000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
294000 USD
us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
542000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
16000 USD
us-gaap Paid In Kind Interest
PaidInKindInterest
184000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
114000 USD
us-gaap Amortization Of Financing Costs And Discounts
AmortizationOfFinancingCostsAndDiscounts
1575000 USD
blgo Gain From Ppp Loan Forgiveness
GainFromPPPLoanForgiveness
43000 USD
blgo Gain From Ppp Loan Forgiveness
GainFromPPPLoanForgiveness
-0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-0 USD
us-gaap Gains Losses On Extinguishment Of Debt
GainsLossesOnExtinguishmentOfDebt
-442000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-23000 USD
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-27000 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
0 USD
us-gaap Provision For Doubtful Accounts
ProvisionForDoubtfulAccounts
11000 USD
us-gaap Depreciation
Depreciation
17000 USD
us-gaap Depreciation
Depreciation
50000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-20000 USD
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
69000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
71000 USD
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
12000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
-27000 USD
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
273000 USD
blgo Increase Decrease In Liability For Customer Deposits
IncreaseDecreaseInLiabilityForCustomerDeposits
79000 USD
blgo Increase Decrease In Liability For Customer Deposits
IncreaseDecreaseInLiabilityForCustomerDeposits
-1000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
114000 USD
us-gaap Increase Decrease In Contract With Customer Liability
IncreaseDecreaseInContractWithCustomerLiability
37000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2962000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-3318000 USD
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
-0 USD
us-gaap Payments To Acquire Interest In Joint Venture
PaymentsToAcquireInterestInJointVenture
100000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
21000 USD
us-gaap Payments For Proceeds From Productive Assets
PaymentsForProceedsFromProductiveAssets
-4000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21000 USD
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-96000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
4120000 USD
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
2380000 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
0 USD
us-gaap Proceeds From Issuance Of Debt
ProceedsFromIssuanceOfDebt
507000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
60000 USD
us-gaap Proceeds From Warrant Exercises
ProceedsFromWarrantExercises
0 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
828000 USD
us-gaap Repayments Of Long Term Debt
RepaymentsOfLongTermDebt
25000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3374000 USD
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
3884000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-9000 USD
us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
-8000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
382000 USD
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
462000 USD
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
716000 USD
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
655000 USD
CY2021Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1098000 USD
CY2020Q3 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations
1117000 USD
us-gaap Interest Paid Net
InterestPaidNet
56000 USD
us-gaap Interest Paid Net
InterestPaidNet
81000 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
0 USD
us-gaap Income Taxes Paid
IncomeTaxesPaid
2000 USD
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
35000 USD
us-gaap Other Significant Noncash Transaction Value Of Consideration Given1
OtherSignificantNoncashTransactionValueOfConsiderationGiven1
0 USD
blgo Commitment Fee Recorded As Additional Paid In Capital
CommitmentFeeRecordedAsAdditionalPaidInCapital
0 USD
blgo Commitment Fee Recorded As Additional Paid In Capital
CommitmentFeeRecordedAsAdditionalPaidInCapital
-122000 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
328000 USD
us-gaap Debt Conversion Original Debt Amount1
DebtConversionOriginalDebtAmount1
3526000 USD
us-gaap Stock Issued1
StockIssued1
0 USD
us-gaap Stock Issued1
StockIssued1
788000 USD
blgo Increase In Liability To Clyra Medical Shareholder
IncreaseInLiabilityToClyraMedicalShareholder
0 USD
blgo Increase In Liability To Clyra Medical Shareholder
IncreaseInLiabilityToClyraMedicalShareholder
129000 USD
blgo Stock Received For Commitment Fee
StockReceivedForCommitmentFee
0 USD
blgo Stock Received For Commitment Fee
StockReceivedForCommitmentFee
70000 USD
blgo Deemed Dividends
DeemedDividends
0 USD
blgo Deemed Dividends
DeemedDividends
100000 USD
blgo Allocation Of Stock Option Expense Within Noncontrolling Interest
AllocationOfStockOptionExpenseWithinNoncontrollingInterest
786000 USD
blgo Allocation Of Stock Option Expense Within Noncontrolling Interest
AllocationOfStockOptionExpenseWithinNoncontrollingInterest
4513000 USD
us-gaap Profit Loss
ProfitLoss
-5103000 USD
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-2962000 USD
CY2021Q3 blgo Working Capital Deficit
WorkingCapitalDeficit
-604000 USD
CY2021Q3 us-gaap Assets Current
AssetsCurrent
1911000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1743000 USD
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1098000 USD
us-gaap Repayments Of Debt
RepaymentsOfDebt
856000 USD
CY2021Q3 us-gaap Long Term Debt
LongTermDebt
1717000 USD
blgo Stock Issued During Period Value Issued For Unpaid Salary And Business Expenses
StockIssuedDuringPeriodValueIssuedForUnpaidSalaryAndBusinessExpenses
43000 USD
blgo Stock Issued During Period Shares Issued For Unpaid Salary And Business Expenses
StockIssuedDuringPeriodSharesIssuedForUnpaidSalaryAndBusinessExpenses
408000
CY2021Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
1098000 USD
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
716000 USD
CY2021Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
12000 USD
us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;"><b><i><span style="text-decoration: underline; ">Credit Concentration</span></i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We have a limited number of customers that account for significant portions of our revenue. During the <em style="font: inherit;">nine</em> months ended <em style="font: inherit;"> September 30, 2021 </em>and <em style="font: inherit;">2020,</em> we had the following customers that accounted for more than <em style="font: inherit;">10%</em> of consolidated revenues, as follows:</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 54pt; width: 90%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 2pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt 0pt 0pt 2pt;"><b><b>September 30, </b><br/> <b>2021</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>September 30, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>2020</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 66%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer A</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">14</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&lt;10</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer B</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">11</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&lt;10</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer C</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&lt;10</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><span style="-sec-ix-hidden:c79474181">12</span></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer D</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">12</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">&lt;10</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">We had <span style="-sec-ix-hidden:c79473975">three</span> customers that each accounted for more than 10% of consolidated accounts receivable at <em style="font: inherit;"> September 30, 2021, </em>and <span style="-sec-ix-hidden:c79473981">two</span> customers at <em style="font: inherit;"> December </em><em style="font: inherit;">31,</em> <em style="font: inherit;">2020,</em> as follows:</p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;"> </p> <table border="0" cellpadding="0" cellspacing="0" class="finTable" style="margin-right: 10%; margin-left: 54pt; width: 90%; font-size: 10pt; font-family: Times New Roman; text-indent: 0px;"><tbody><tr style="vertical-align: bottom;"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>September 30, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>2021</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> </td><td colspan="2" style="text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0); border-top: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>December 31, </b></b></p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;text-align:right;margin:0pt;"><b><b>2020</b></b></p> </td><td style="font-family: Times New Roman; font-size: 10pt; padding-bottom: 1px;"> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; width: 66%;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer C</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">19</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&lt;10</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer D</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">16</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&lt;10</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer E</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">13</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&lt;10</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(255, 255, 255);"><td style="font-family: Times New Roman; font-size: 10pt;"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer F</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"><em style="font: inherit;">&lt;10</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt;"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;">32</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td></tr> <tr style="vertical-align: bottom; background-color: rgb(204, 238, 255);"><td style="font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family: Times New Roman; font-size: 10pt; font-variant: normal; margin-top: 0pt; margin-bottom: 0pt;">Customer G</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"><em style="font: inherit;">&lt;10</em></td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; border-bottom: 1px solid rgb(0, 0, 0);"> </td><td style="width: 14%; text-align: right; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; border-bottom: 1px solid rgb(0, 0, 0);">10</td><td style="width: 1%; font-family: Times New Roman; font-size: 10pt; margin-left: 0pt; padding-bottom: 1px;"> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;">%</p> </td></tr> </tbody></table> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q3 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
100000 USD
CY2020Q4 us-gaap Inventory Raw Materials Net Of Reserves
InventoryRawMaterialsNetOfReserves
111000 USD
CY2021Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
150000 USD
CY2020Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
166000 USD
CY2021Q3 us-gaap Inventory Net
InventoryNet
250000 USD
CY2020Q4 us-gaap Inventory Net
InventoryNet
277000 USD
CY2021Q3 us-gaap Security Deposit
SecurityDeposit
35000 USD
CY2021Q3 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0 USD
us-gaap Use Of Estimates
UseOfEstimates
<p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt 0pt 0pt 36pt;"><b><i><span style="text-decoration: underline; ">Use of Estimates </span></i></b></p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, the disclosure of contingent assets and liabilities at the date of the financial statements, and revenues and expenses during the period reported. Actual results could differ from those estimates. Estimates are used when accounting for stock-based transactions, debt transactions, derivative liabilities, allowance for bad debt, asset depreciation and amortization, among others.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p> <p style="font-family:Times New Roman;font-size:10pt;font-variant:normal;margin:0pt;text-indent:36pt;">The methods, estimates and judgments we use in applying these most critical accounting policies have a significant impact on the results of our financial statements.</p> <p style="font-family:'Times New Roman';font-size:10pt;font-variant:normal;margin:0pt;"> </p>
CY2021Q3 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0 USD
CY2021Q3 us-gaap Line Of Credit
LineOfCredit
0 USD
CY2020Q4 us-gaap Line Of Credit
LineOfCredit
50000 USD
CY2021Q3 blgo Note Payable And Line Of Credit Current
NotePayableAndLineOfCreditCurrent
0 USD
CY2020Q4 blgo Note Payable And Line Of Credit Current
NotePayableAndLineOfCreditCurrent
100000 USD
CY2021Q3 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
0 USD
CY2020Q4 us-gaap Convertible Notes Payable Current
ConvertibleNotesPayableCurrent
1106000 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
-0 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Current
DebtInstrumentUnamortizedDiscountCurrent
104000 USD
CY2021Q3 us-gaap Debt Current
DebtCurrent
0 USD
CY2021Q3 us-gaap Share Price
SharePrice
0.19
CY2021Q3 us-gaap Share Price
SharePrice
0.19
CY2020Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
32980989
blgo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
7865872
blgo Class Of Warrant Or Right Exercised During Period
ClassOfWarrantOrRightExercisedDuringPeriod
416667
CY2021Q3 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
390000 USD
CY2020Q4 us-gaap Debt Current
DebtCurrent
1102000 USD
CY2021Q3 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
25000 USD
CY2020Q4 us-gaap Debt Instrument Unamortized Discount Noncurrent
DebtInstrumentUnamortizedDiscountNoncurrent
-0 USD
CY2021Q3 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
489000 USD
CY2020Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
507000 USD
CY2021Q3 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
489000 USD
CY2020Q4 us-gaap Debt Longterm And Shortterm Combined Amount
DebtLongtermAndShorttermCombinedAmount
1609000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
208000 USD
us-gaap Interest Expense Debt
InterestExpenseDebt
1823000 USD
blgo Price Range Warrants Exercised
PriceRangeWarrantsExercised
0.14
blgo Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
2743406
CY2021Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
37686788
CY2021Q3 blgo Class Of Warrant Or Right Aggregate Value Of Warrants Or Rights
ClassOfWarrantOrRightAggregateValueOfWarrantsOrRights
140000 USD
CY2019Q4 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
43231161
blgo Class Of Warrant Or Right Issued During Period
ClassOfWarrantOrRightIssuedDuringPeriod
5427648
blgo Class Of Warrant Or Right Expired During Period
ClassOfWarrantOrRightExpiredDuringPeriod
14272820
CY2020Q3 us-gaap Class Of Warrant Or Right Outstanding
ClassOfWarrantOrRightOutstanding
34385989
CY2021Q3 us-gaap Share Price
SharePrice
0.19
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
CY2021Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
712000 USD
CY2020Q3 us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
666000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1743000 USD
us-gaap Revenue From Contract With Customer Including Assessed Tax
RevenueFromContractWithCustomerIncludingAssessedTax
1522000 USD
CY2021Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1455000 USD
CY2020Q3 us-gaap Operating Income Loss
OperatingIncomeLoss
-1909000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5013000 USD
us-gaap Operating Income Loss
OperatingIncomeLoss
-5615000 USD
CY2021Q3 us-gaap Interest Expense
InterestExpense
26000 USD
CY2020Q3 us-gaap Interest Expense
InterestExpense
318000 USD
us-gaap Interest Expense
InterestExpense
208000 USD
us-gaap Interest Expense
InterestExpense
1823000 USD
CY2021Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
344000 USD
CY2020Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
347000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1027000 USD
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
1031000 USD
CY2021Q3 blgo Finitelived Tangible Assets Net
FinitelivedTangibleAssetsNet
2798000 USD
CY2021Q3 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
296000 USD
CY2021Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2150000 USD
CY2020Q4 blgo Finitelived Tangible Assets Net
FinitelivedTangibleAssetsNet
2388000 USD
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
341000 USD
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2150000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
170000 USD
us-gaap Operating Lease Expense
OperatingLeaseExpense
167000 USD

Files In Submission

Name View Source Status
0001437749-21-026755-index-headers.html Edgar Link pending
0001437749-21-026755-index.html Edgar Link pending
0001437749-21-026755.txt Edgar Link pending
0001437749-21-026755-xbrl.zip Edgar Link pending
blgo-20210930.xsd Edgar Link pending
blgo-20210930_cal.xml Edgar Link unprocessable
blgo-20210930_def.xml Edgar Link unprocessable
blgo-20210930_lab.xml Edgar Link unprocessable
blgo-20210930_pre.xml Edgar Link unprocessable
blgo20210930_10q.htm Edgar Link pending
blgo20210930_10q_htm.xml Edgar Link completed
ex_306121.htm Edgar Link pending
ex_306122.htm Edgar Link pending
ex_306123.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending